Product Images Donepezil

This is a table showing the change in ADAS cog (a measure of cognitive functioning) for different treatment groups for a medication called Donepezil Hydrochloride, and a placebo. The table shows the percentage of participants who experienced improvement in cognitive functioning after taking the medication or placebo for a period of time. The dosage of the medication varied among the different treatment groups. The table also includes a graph that shows the change from baseline for each treatment group. No additional context or information is available.*

This appears to be a table of cumulative percentage of patients in a clinical study evaluating the efficacy of Donepezil Hydrochloride for the treatment of Alzheimer's disease. The study has three treatment groups: Donepezil Hydrochloride 10 mg/day, Donepezil Hydrochloride 5 mg/day and placebo. The table shows the change in ADAS-Cog (Alzheimer's Disease Assessment Scale-cognitive subscale) score (a measure of cognitive function) from baseline after a certain duration of treatment. However, without more information or context, it is difficult to provide a complete understanding of the study results.*

This appears to be a partially incomplete document. The first line indicates a dosage of Donepezil Hydrochloride of 10 ml per day, while the second line states "Placebo". Further context is not available, and it is not clear what the document is discussing.*

This is a description of a medication package for Donepezil Heli, which is a tablet used to treat dementia in Alzheimer's disease. It contains 10mg of the active ingredient and is intended to be taken according to a doctor's instructions. The tablets should be stored at room temperature and have an expiration date of MMYY. The package was produced by Bryant Ranch Prepack and has a product number of 91500, with a yellow round pill format. The National Drug Code for this product is 7133507921, and it is comparable to the prescription drug Aricept.*